Ken Griffin Liva Nova PLC Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$43.38 - $54.59 $1.05 Million - $1.33 Million	-24,300 Reduced 40.84%	35,200 $1.85 Million
Q2 2024 Aug 14, 2024	BUY	$51.76 - $64.15 $2.27 Million - $2.82 Million	43,900 Added 281.41%	59,500 $3.26 Million
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $58,320 - $68,544	1,200 Added 8.33%	15,600 $872,000
Q4 2023 Feb 14, 2024	SELL	$43.45 - $53.66 $160,765 - $198,542	-3,700 Reduced 20.44%	14,400 $745,000
Q3 2023 Nov 14, 2023	BUY	$50.12 - $58.87 $175,420 - $206,045	3,500 Added 23.97%	18,100 $957,000
Q2 2023 Aug 14, 2023	BUY	$42.28 - $51.43 $515,816 - $627,446	12,200 Added 508.33%	14,600 $750,000
Q1 2023 May 15, 2023	SELL	$40.84 - $58.14 $392,064 - $558,144	-9,600 Reduced 80.0%	2,400 $104,000
Q4 2022 Feb 14, 2023	SELL	$43.88 - $56.16 $1.08 Million - $1.38 Million	-24,600 Reduced 67.21%	12,000 $666,000
Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $29,022 - $39,900	-600 Reduced 1.61%	36,600 $1.86 Million

262

53M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.76B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.